Documentation Centre

 

 

  of 1525 Next page

Go to page: of

Screenshot Date Categories Title Author Format
Plasma levels of free fatty acids correlate with type 2 diabetes mellitus. Diabetes Obes Metab. 2018;20:2661-2669. January 15, 2019 Plasma levels of free fatty acids correlate with type 2 diabetes mellitus. Diabetes Obes Metab. 2018;20:2661-2669. Spiller S, Blüher M, Hoffmann R Key Publications
Can the plasma concentration ratio of triglyceride/high-density lipoprotein cholesterol identify individuals at high risk of cardiovascular disease during 40-year follow-up? Metab Syndr Relat Disord. 2018;16:433-439 January 11, 2019 Can the plasma concentration ratio of triglyceride/high-density lipoprotein cholesterol identify individuals at high risk of cardiovascular disease during 40-year follow-up? Metab Syndr Relat Disord. 2018;16:433-439 Lind L, Ingelsson E, Ärnlöv J, Sundström J, Zethelius B, Reaven GM Key Publications
Association of fish and long-chain omega-3 fatty acids intakes with total and cause-specific mortality: prospective analysis of 421 309 individuals. J Intern Med. 2018;284:399-417 January 08, 2019 Association of fish and long-chain omega-3 fatty acids intakes with total and cause-specific mortality: prospective analysis of 421 309 individuals. J Intern Med. 2018;284:399-417 Zhang Y, Zhuang P, He W, Chen JN, Wang WQ, Freedman ND, Abnet CC, Wang JB, Jiao JJ Key Publications
LDL cholesterol rises with BMI only in lean individuals: Cross-sectional U.S. and Spanish representative data. Diabetes Care. 2018;41:2195-2201 January 07, 2019 LDL cholesterol rises with BMI only in lean individuals: Cross-sectional U.S. and Spanish representative data. Diabetes Care. 2018;41:2195-2201 Laclaustra M, Lopez-Garcia E, Civeira F, Garcia-Esquinas E, Graciani A, Guallar-Castillon P, Banegas JR, Rodriguez-Artalejo F Key Publications
Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018;14:576-590 December 28, 2018 Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018;14:576-590 Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A Key Publications
Effects of oils and solid fats on blood lipids: a systematic review and network meta-analysis. J Lipid Res. 2018;59:1771-1782 December 20, 2018 Effects of oils and solid fats on blood lipids: a systematic review and network meta-analysis. J Lipid Res. 2018;59:1771-1782 Schwingshackl L, Bogensberger B, Benčič A, Knüppel S, Boeing H, Hoffmann G Key Publications
Clusters of fatty acids in the serum triacylglyceride fraction associate with the disorders of type 2 diabetes. J Lipid Res. 2018;59:1751-1762 December 19, 2018 Clusters of fatty acids in the serum triacylglyceride fraction associate with the disorders of type 2 diabetes. J Lipid Res. 2018;59:1751-1762 Johnston LW, Liu Z, Retnakaran R, Zinman B, Giacca A, Harris SB, Bazinet RP, Hanley AJ Key Publications
Plasma concentrations of molecular lipid species predict long-term clinical outcome in coronary artery disease patients. J Lipid Res. 2018;59:1729-1737 December 19, 2018 Plasma concentrations of molecular lipid species predict long-term clinical outcome in coronary artery disease patients. J Lipid Res. 2018;59:1729-1737 Anroedh S, Hilvo M, Akkerhuis KM, Kauhanen D, Koistinen K, Oemrawsingh R, Serruys P, van Geuns RJ, Boersma E, Laaksonen R, Kardys I Key Publications
Total/high density lipoprotein cholesterol and cardiovascular disease (re)hospitalization nadir in type 2 diabetes. J Lipid Res. 2018;59:1745-1750 December 19, 2018 Total/high density lipoprotein cholesterol and cardiovascular disease (re)hospitalization nadir in type 2 diabetes. J Lipid Res. 2018;59:1745-1750 Yu D, Cai Y, Qin R, Graffy J, Holman D, Zhao Z, Simmons D Key Publications
Efficacy and safety of alirocumab in individuals with type 2 diabetes mellitus with or without mixed dyslipidaemia: Analysis of the ODYSSEY LONG TERM trial. Atherosclerosis. 2018;276:124-130 December 18, 2018 Efficacy and safety of alirocumab in individuals with type 2 diabetes mellitus with or without mixed dyslipidaemia: Analysis of the ODYSSEY LONG TERM trial. Atherosclerosis. 2018;276:124-130 Taskinen MR, Del Prato S, Bujas-Bobanovic M, Louie MJ, Letierce A, Thompson D, Colhoun HM Key Publications

  of 1525 Next page

Go to page: of